Introduction
Laparoscopic surgery is a common surgical practice, with advantages over open procedures. Advantages include a shorter hospital stay, an earlier return to normal activities, better quality of life after surgery, and better cosmetic results. [1] [2] [3] Despite these conveniences, many patients complain about shoulder pain and pain in the upper abdomen after laparoscopy. The incidence of shoulder pain after laparoscopy has been estimated to range from 35 to 80%. [4] [5] [6] [7] [8] [9] [10] Post-laparoscopic shoulder pain can be even worse than pain at the incision site. 8 As a result of early discharge nowadays, post-laparoscopic pain may be out of sight of the medical doctor and not treated properly.
Laparoscopy-induced pain is still not fully understood. Several factors may contribute to the laparoscopy-induced pain, such as rapid distension of the peritoneum, which results in traumatic traction on blood vessels and nerves, with inflammatory mediator release and phrenic nerve neuropraxia. [11] [12] [13] Furthermore, the phrenic nerve and diaphragm may be damaged by the acidotic and cooling effect of insufflated carbon dioxide. 12, [14] [15] [16] [17] Another theory is that post-laporoscopic pain is caused by the retention of carbon dioxide in the abdomen, which irritates the phrenic nerve and diaphragm, and causes referred pain in the shoulder (C4 dermatome) and pain in the upper abdomen. 4, 11, 12, 18 The literature reports a significant correlation between the volume of residual carbon dioxide, as measured from a standing chest X-ray, and pain scores. 4, 11, 18, 19 It is not clear whether the length of the surgical procedure has an influence on the intensity or incidence of post-laparoscopic pain. 20, 21 To reduce post-laparoscopic pain after gynaecological surgery, two promising strategies are mentioned in the literature. 1, 22, 23 The first is the pulmonary recruitment manoeuvre, which is originally designed to open alveoli. The increased intrapulmonary pressure results in an increase of intraperitoneal pressure, which facilitates the removal of residual carbon dioxide from the abdomen. 9, [22] [23] [24] [25] A second method is the use of intraperitoneal normal saline infusion. Filling the abdomen with warm saline facilitates carbon dioxide rising and escaping through the port sites. 26 In addition, normal saline is thought to offer a physiological buffer system to dissolve excess carbon dioxide. 22 A combination of the two techniques described above reduced the incidence of shoulder pain in a randomised controlled trial (RCT) 48 hours after surgery in Asian women with a mean body weight of <60 kg (50 versus 30%). 23 The aim of this study is to assess the effect of intraperitoneal normal saline infusion combined with a pulmonary recruitment manoeuvre on post-laparoscopic pain in women undergoing gynaecological laparoscopic surgery. 27 
Methods
We performed an RCT in one university hospital and one teaching hospital in the Netherlands: Maastricht University Medical Centre (Maastricht) and M axima Medical Centre (Veldhoven). Patients were included from 1 February 2015 to 31 December 2016. Approval for the study was obtained from the local ethics committee of M axima Medical Centre (METC no 1445, CCMO no. NL50655.015.14). No funding was required or received.
We included women between 18 and 65 years of age, with American Society of Anaesthesiologists (ASA) physical status classification I-II, who were scheduled for an elective laparoscopic procedure for a benign gynaecological indication. Patients were counselled for the trial and written informed consent was obtained. Randomisation was stratified by hospital and performed using sealed envelopes, which were opened just before the end of the surgery. The study was blinded for patients, nurses, house officers on the ward, and the researcher. Only the surgical team was aware of the allocation.
In the intervention group, patients were placed in the Trendelenburg position of 30°at the end of the laparoscopic procedure. Then, 15-20 ml/kg of warm saline was intraperitoneally infused into the abdomen, followed by five pulmonary insufflations with a pressure of 40 cm H 2 O (pulmonary recruitment manoeuvre) by the anaesthesiologist. The fifth insufflation was held for 5 seconds. During these positive pressure insufflations, the trocar sleeve valves were fully opened in order to remove carbon dioxide from the abdominal cavity. Hereafter, patients were placed in the neutral position, followed by the removal of the trocars.
In the control group, carbon dioxide was removed in the neutral position with gentle abdominal pressure and passive exsufflation through the open trocar sleeve valves in the abdomen.
All patients received perioperative local (periportal) infiltration with ropivacaine or bupivacaine. Carbon dioxide was used as distension medium, introduced through a Veress needle placed intraumbilically or at Palmer's point. The gas pressure was set at 14 mmHg during the procedure. For intraoperative analgesia, sufentanil was used. After surgery, patients received paracetamol 1000 mg every 6 hours and naproxen 500 mg twice a day, on demand. Breakthrough pain was treated with oral opioids, unless severe postoperative nausea and vomiting mandated subcutaneous or intravenous administration.
After surgery, the surgeon reported the type of surgery, ASA classification, duration of surgery, estimated blood loss, and total volume of gas used. Participants received a questionnaire with a pre-paid return envelope. Primary outcomes were the incidence and intensity of self-reported post-laparoscopic pain in shoulder 48 hours after surgery. We also reported the incidence and intensity of pain in the upper abdomen, and pain at the operating site. Pain was measured using a visual analogue scale (VAS). The VAS score is a measurement instrument ranging from 0 to 10 cm (0 cm, no pain; 10 cm, worst pain imaginable). Secondary outcomes were postoperative use of analgesics, nausea, vomiting, and pulmonary complications.
Currently, there are no generally accepted or available core outcome sets dealing with postoperative pain or postlaparoscopic pain. A time period of 48 hours was used, as post-laparoscopic pain is usually short-lived and declines further after 48 hours.
7,9,10 Our outcome measures cover the incidence of pain and pain intensity. In the absence of a gold standard for pain intensity, the VAS score is a wellaccepted tool for adults. To interpret these data, the use of analgesics was taken into account.
Sample size
Post-laparoscopic pain is most common and evident in the first 48 hours after surgery, whereafter the pain declines. We used the results on pain intensity from Tsai et al. 23 at 48 hours after surgery to calculate the sample size. For the incidence of shoulder pain, we assumed a reduction of 30% by the combination of saline and the pulmonary recruitment manoeuvre 48 hours after laparoscopy. 9, 23 We anticipated a dropout rate of 20% because of loss to follow-up or incomplete questionnaires. With an alpha value of 5% and a power of 85%, the sample size needed for testing our primary end point was 126 women, with 63 women in each arm. At the end of the inclusion period, however, there seemed to be an unequal randomisation. The unequal randomisation is likely to have been caused by using simple randomisation instead of stratified block randomisation. We requested an amendment to extent our study population to achieve a total number of 200, which was approved by the ethics committee.
Statistical analysis
Baseline characteristics were presented as mean and standard deviation if normally distributed, and otherwise as a median with an interquartile range (IQR) or absolute value and percentage. We classified patients as having pain or not by using the questionnaires, comparing the intervention and control groups using Pearson's chi-square statistic. To correct for potential baseline imbalance, defined as clinically relevant differences in baseline characteristics, we used logistic regression analysis. For those who did experience pain, we compared the average pain scores between groups. We used Student's t-tests for pain scores that were normally distributed. Linear regression was used to correct for baseline imbalance, if present. The primary focus was the difference between groups at 48 hours after the procedure, but we also calculated VAS scores 8 and 24 hours after the procedure. For the analysis of the secondary outcomes, we compared them over the whole period of 48 hours of follow-up. Data were analysed according to the intention-to-treat principle. Significance was tested two-sided with an alpha level of 0.05. Statistical analysis was performed using SPSS 22 (IBM).
Results
In total, 200 participants were included, resulting in 100 women in each arm. Sample size calculation showed 126 inclusions were needed to reach a power of 85%. We provided both hospitals with a surplus of envelopes, with 100 supplied to each hospital. Erroneously, we used simple randomisation, instead of using stratified block randomisation, resulting in unequal randomisation after the initial 126 women had been recruited (with 56 women in the control group and 71 women in the intervention group). To correct for the unequal randomisation, we gained permission from the medical ethics committee to enlarge our study population to 200, which corresponded with the number of envelopes in the initial randomisation. As the distribution of the allocation was 50 : 50 within all envelopes, in the end the same distribution was found among inclusions.
We observed a dropout rate of 11.5%, which is below the anticipated 20% (Figure 1 ). Data for dropouts were not included in our calculations, as we did not have any reliable results for the patients who did not return or did not correctly fill in the questionnaires.
Demographic characteristics and operative details are presented in Table 1 . Most prognostic factors are evenly distributed over both groups; however, we observed that the mean duration of surgery and mean volume of gas used during surgery were higher in the intervention group compared with the control group.
The mean volume of normal saline used in the intervention group was 1329 ml, with a minimum of 850 ml and a maximum of 2000 ml.
Incidence of pain

Shoulder pain
The incidence of pain at 48 hours after surgery was 21% in the intervention group and 25% in the control group (P = 0.57; Table 2 ). We observed no statistically significant differences in the incidence of pain at 8 and 24 hours after surgery between the intervention group and the control group (38 versus 50% and 32 versus 42%, respectively; P = 0.11 and P = 0.14).
Abdominal pain
The frequency of abdominal pain did not significantly differ between the groups at any of the three time points. The intervention group reported abdominal pain in 64, 60, and 49% of patients at 8, 24, and 48 h, respectively, compared with 59, 58, and 45% in the control group.
Incisional pain
The intervention group mentioned a significantly higher incidence of incisional pain at 8 and 24 hours after surgery (96 versus 86% and 98 versus 89%, respectively; P = 0.03 and P = 0.02). No significant difference was observed 48 hours after surgery.
Pain in the total period
In the total study period of 48 hours, 46% of participants in the intervention group reported shoulder pain at some point versus 55% in the control group. This difference was not statistically significant (P = 0.26). Abdominal pain was reported in 71% of cases in the intervention group versus 68% in the control group. For incisional pain these percentages were 99 and 93%, respectively. Figure 2 shows the mean VAS scores of participants who reported pain.
Pain intensity
Shoulder pain
The mean VAS scores of participants who reported shoulder pain did not statistically differ between groups at any time point. 
Abdominal pain
The mean VAS score of abdominal pain at 8 hours after surgery was significantly lower in the intervention group compared with the control group (3.2 versus 4.2, P = 0.02). With regards to abdominal pain at 24 and 48 hours after surgery, there was no statistical difference between the groups.
Incisional pain
The intensity of incisional pain was higher in the intervention group at 48 hours after surgery (3.5 versus 2.9, P = 0.05).
Analgesic requirements
We observed no difference in the use of analgesics between the groups in the total period of 48 hours (Table 3) . Breakthrough pain was treated with oral opioids (oxycodon 5 mg), which ranged from 0 to 6 tablets. The number of doses and total doses used did not differ between the groups.
Nausea and vomiting
Regarding reported nausea and vomiting, there was no significant difference between the intervention group and the control group, although the proportion of women who reported vomiting was about twice as high in the intervention group (Table 4 ).
Pulmonary problems
No pulmonary problems were recorded in either group.
We corrected for baseline imbalance in the duration of surgery and the volume of gas used. After adjustments in the analyses, the results did not differ for any of the outcome variables.
Discussion
Main findings
The results of this multi-centre, randomised trial show that the combination treatment of the pulmonary recruitment manoeuvre with intraperitoneal infusion of saline does not influence the incidence or the intensity of post-laparoscopic shoulder pain.
The incidence of shoulder pain did not significantly differ between the groups at 8, 24, and 48 hours after laparoscopy. In both groups the incidence of shoulder pain was highest after 8 hours. After 24 and 48 hours the pain incidence decreased in both groups. No differences in upper abdominal pain were found.
The intensity (VAS scores) of shoulder pain did not differ between the intervention group and the control group at any of the three end points. Abdominal pain at 8 hours after surgery was significantly lower in the intervention group compared with the control group. This difference was not observed at 24 or 48 hours after surgery. VAS scores of pain at incision sites did not differ between the two groups at 8 and 24 hours, but were significantly higher in the intervention group at 48 hours after surgery.
Strengths and limitations
Important strengths of this study include the prospective and randomised design, with a standard perioperative procedure for all patients and a standard pressure pneumoperitoneum. Our questionnaire return rate was 88.5%, which is considered to be high. This means we had a dropout rate of 11.5%, which is below the estimated dropout rate of 20%. The impact of non-responder bias is likely to be negligible. 28 We measured analgesic use, which is of great importance when measuring pain scores. Recording analgesic use allows for a more accurate interpretation of the VAS scores.
Our study also has some limitations. Although we randomised our population with a randomisation program using sealed envelopes, we observed an unequal randomisation. This probably resulted from using simple randomisation instead of using stratified block randomisation. We requested an amendment to include more patients to reach a total number of 200, which corresponded with the number of envelopes in the initial randomisation. This request was approved by the ethics committee. This enlargement of the group was not necessary to reach the estimated power of 85%, but to get two equal groups. Besides, we observed a difference between groups for length of surgery and volume of gas used during surgery, which was higher in the intervention group than in the control group. However, we corrected for these differences, and this imbalance in baseline characteristics had no effect on the outcome variables.
Interpretation
Our findings are inconsistent with the findings of Tsai et al., 23 who compared the combination treatment with a control group. In their study, significant differences in the frequency and intensity of shoulder pain were observed at 12, 24, and 48 hours after surgery, and for abdominal pain at 12 and 24 hours after surgery. Although we assessed the same intervention, there was a difference in mean surgery time, which was 145.5 minutes for the intervention group and 148.2 minutes for the control group in the study of Tsai et al. In our study the mean surgery time was 89 minutes in the intervention group and 66.5 minutes in the control group. It may be the case that the beneficial effects of the interventions are only present with longer and more elaborate surgery. The difference in surgery time is probably linked to the fact that we also included less extensive forms of surgery, whereas the study by Tsai et al. did not.
Moreover, the data included in the study of Tsai et al. 23 were clearly highly skewed: as the SDs were larger than the means, they used parametric t-tests to test for significance in VAS scores. To solve the skewed distributed data, we excluded patients with VAS 0 (no pain), and tested for differences in pain, given that pain is experienced. In our Table 4 . Nausea and vomiting in total period of time data, this selection resulted in roughly normally distributed pain scores, which justifies the use of Student's t-tests.
Overall pain scores were lower in our study than in the study of Tsai et al., which may be attributed to the use of different kinds of analgesics, the inclusion of less extensive surgery in our study, and/or any ethnic differences in the perception of pain. 29 The perception of pain has not been studied between women from the Netherlands and women from Taiwan, and therefore we cannot determine whether this was an influence on the difference in outcome between our study and the study of Tsai et al.
The incidence of pain at the incision sites was lower in the control group compared with the intervention group. An explanation may be that intraperitoneal saline causes more tension on the incision sites, which may cause pain. Most of the literature on intraperitoneal saline infusion did not look at pain at the incision sites; however, our results are discordant with the studies of Tsai et al. 22, 23 We did not observe any side effects of the intervention. The percentages of patients who experienced postoperative nausea and vomiting were not significantly different between the two groups. This is in accordance with the results of Tsai et al. 22 Other studies also showed no differences in nausea and vomiting, or even found fewer of these complaints when only the pulmonary recruitment manoeuvre, 9 or the intraperitoneal saline infusion, 30, 31 were used. We used on average 1300 ml of normal saline intraperitoneally, with a maximum volume of 2000 ml. No pulmonary complaints or complications were reported, which also makes the combination method a safe procedure for women with a higher average body mass index (mean BMI 26.2), compared with the women in the study of Tsai et al. 23 (mean BMI 22.7). We think postoperative pain reduction is very important for our patients, even more in day-care practice. We copied the study from Tsai et al. to compare the frequency and intensity of post-laparoscopic pain after a combination treatment of the pulmonary recruitment manoeuvre and intraperitoneal saline infusion, compared with a control group. We showed no difference in the incidence of shoulder pain after laparoscopy using a combination treatment. Nor did we find lower pain scores. We showed a slight reduction of pain intensity (upper abdominal pain) at 8 hours after laparoscopy. This is interesting, because patients with ambulatory surgery will be at home 8 hours after surgery; however, more pain at the incision sites was seen in the intervention group, which could nullify the previous advantage.
Conclusion
Improving the circumstances for patients who go home after surgery was the main motivation for this randomised controlled trial. 23 The combination treatment of pulmonary recruitment manoeuvre with intraperitoneal infusion of normal saline does not influence the incidence and intensity of post-laparoscopic shoulder pain. It marginally decreases VAS scores of shortterm post-laparoscopic upper abdominal pain. Therefore we advise to be reluctant regarding the adoption of this combination treatment into daily clinical practice.
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